September 4, 2017 / 10:27 AM / 3 months ago

BRIEF-Gongwin Biopharm Holdings unit gets approval for clinical trial on PTS100

Sept 4 (Reuters) - Gongwin Biopharm Holdings Co Ltd :

* Says its wholly owned phrama tech subsidiary got approval from Ministry of Health and Welfare for clinical trial on PTS100

* PTS100 is a kind of minimal invasive interventional therapy tool for HCC

Source text in Chinese: goo.gl/VZaKKT

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below